Insulin Analog

Diabetes Mellitus, Type 1

Diabetes Mellitus, Type 2

Hyperglycemia

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-10"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Insulin glargine is a long-acting human insulin analog produced by recombinant DNA technology utilizing a nonpathogenic laboratory strain of <span class="Italics">Escherichia coli</span> (K12) as the production organism. Insulin glargine differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine and two arginines remain at the C-terminus of the B-chain. Insulin glargine has a molecular weight of 6063 Da.</p><p>TOUJEO (insulin glargine) injection is a sterile, clear and colorless solution for subcutaneous injection. Each mL of TOUJEO contains 300 units of insulin glargine dissolved in a clear aqueous fluid.</p><p>The 1.5 mL TOUJEO SoloStar prefilled pen presentation contains the following inactive ingredients per mL: glycerin (20 mg), metacresol (2.7 mg), zinc (90 mcg), and Water for Injection, USP.</p><p>The 3 mL TOUJEO Max SoloStar prefilled pen presentation contains the following inactive ingredients per mL: glycerin (20 mg), metacresol (2.7 mg), zinc (90 mcg), and Water for Injection, USP.</p><p>The pH is adjusted by addition of aqueous solutions of hydrochloric acid and sodium hydroxide. TOUJEO has a pH of approximately 4.</p></section>

TOUJEO

1.5 ML insulin glargine 300 UNT/ML Pen Injector

Toujeo

1.5 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo]

3 ML insulin glargine 300 UNT/ML Pen Injector

3 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo]

insulin glargine

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event

Prescribing Information

Medication Guide 

Submit MSL Request 

Formulary Information

Online Sample Form 

Pharmacy List 

Coverage Authorization Request 

Coverage Authorization Appeals 

Letter of Medical Necessity 

Sanofi Patient Connection Enrollment Form 

Sanofi Patient Connection Enrollment Form - Spanish

Sanofi Patient Connection - HCP Office Portal 

Enroll in Patient Savings Program 

Sanofi Patient Connection Assistance - Patient 

Device Options

Other HCP Resources

Blood Sugar Tracker 

Meal Planning & Exercise Tips 

Meal Planning & Exercise Tips - Spanish

Hypoglycemia Safety 

Hypoglycemia Safety - Spanish

Blood Sugar Tracker - Spanish

About Toujeo - New To Insulin 

About Toujeo - Already on Insulin 

Taking Toujeo

Patient Resources 

Doctor Discussion Guide 

Instructions For Use (SoloStar Pen): Type 2 Diabetes 

Instructions For Use (Max SoloStar): Type 2 Diabetes 

Toujeo Patient Support 